- Home
- FLUX vs CALC Comparison
FLUX vs CALC Comparison
Compare FLUX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- CALC
- Stock Information
- Founded
- FLUX N/A
- CALC 2011
- Country
- FLUX United States
- CALC United States
- Employees
- FLUX N/A
- CALC N/A
- Industry
- FLUX Industrial Machinery/Components
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- CALC Health Care
- Exchange
- FLUX Nasdaq
- CALC Nasdaq
- Market Cap
- FLUX 51.4M
- CALC 44.7M
- IPO Year
- FLUX N/A
- CALC N/A
- Fundamental
- Price
- FLUX $2.32
- CALC $3.45
- Analyst Decision
- FLUX Strong Buy
- CALC Strong Buy
- Analyst Count
- FLUX 4
- CALC 4
- Target Price
- FLUX $9.50
- CALC $19.50
- AVG Volume (30 Days)
- FLUX 67.9K
- CALC 95.9K
- Earning Date
- FLUX 11-29-2024
- CALC 11-13-2024
- Dividend Yield
- FLUX N/A
- CALC N/A
- EPS Growth
- FLUX N/A
- CALC N/A
- EPS
- FLUX N/A
- CALC N/A
- Revenue
- FLUX $63,850,000.00
- CALC N/A
- Revenue This Year
- FLUX N/A
- CALC N/A
- Revenue Next Year
- FLUX $13.51
- CALC N/A
- P/E Ratio
- FLUX N/A
- CALC N/A
- Revenue Growth
- FLUX N/A
- CALC N/A
- 52 Week Low
- FLUX $2.02
- CALC $2.68
- 52 Week High
- FLUX $5.86
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- FLUX 34.95
- CALC 42.37
- Support Level
- FLUX $2.02
- CALC $3.27
- Resistance Level
- FLUX $2.28
- CALC $3.47
- Average True Range (ATR)
- FLUX 0.22
- CALC 0.15
- MACD
- FLUX -0.03
- CALC 0.01
- Stochastic Oscillator
- FLUX 22.99
- CALC 41.86
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.